Skip to main content

Diabetes

  • Walgreens re-ups alliance with American Diabetes Association through 2013

    ALEXANDRIA, Va. — The American Diabetes Association on Wednesday announced that Walgreens has reaffirmed its commitment as a National Strategic Partner and will continue to help the program Stop Diabetes by supporting the association's Type 2 diabetes prevention initiative for consumers called CheckUp America. 

  • Study: Regular blood glucose monitoring increases medication adherence

    MILPITAS, Calif. — Blood glucose monitoring is associated with reduced A1C levels and greater adherence to medication in Type 2 diabetes patients who do not take insulin, according to a study published in the September issue of Diabetes Technology & Therapeutics.

  • Colgate survey shows surprising lack of awareness around diabetes and oral health

    Colgate Total and the American Diabetes Association teamed up to promote awareness for American Diabetes Month with a survey revealing people's knowledge — or lack thereof — about oral health and its association with diabetes.

    The survey, conducted by Harris Interactive, found that 36% of respondents didn't know about the link between diabetes and oral health, and 66% of respondents didn't realize that people with diabetes are twice as likely to develop serious gum disease.

  • Nipro Diagnostics garners Consumer Reports recommendation for the second consecutive year

     NEW YORK — Nipro Diagnostics' TRUEresult Blood Glucose Meter for the second consecutive year received a “recommended“ rating from Consumer Reports as part of the publication's review of blood glucose meters in its October issue. 

    The TRUEresult meter received an “excellent” rating for accuracy and “very good“ for repeatability and convenience. Additionally, the TRUE2go meter rated “very good” for accuracy and repeatability, and “good” for convenience. 

  • Rite Aid, UnitedHealth Group offer diabetes services to Long Island, N.Y., residents

    CAMP HILL, Pa. — Rite Aid pharmacists on Long Island in New York state are participating in a diabetes initiative run by health insurer UnitedHealth Group, the two companies said Thursday.

    The pharmacists are part of the Diabetes Control Program, itself part of UnitedHealth's Diabetes Prevention and Control Alliance. The program is available to residents of the island enrolled in UnitedHealthcare's employer-sponsored health plans.

  • Lilly, BI diabetes drug shows greater A1C reduction in African-American adults than placebo, study shows

    RIDGEFIELD, Conn. — A drug used to treat Type 2 diabetes produced significant reduction in blood sugar in African-American patients, according to results of a late-stage clinical trial.

    Boehringer Ingelheim Pharmaceuticals and Eli Lilly announced Thursday results of a phase-3 trial of Tradjenta (linagliptin) in which 226 patients with Type 2 diabetes received 5 mg of the drug once per day or placebo.

  • Blood Sugar Basics Game Plan seeks to help Type 2 diabetics better manage condition

    PHILADELPHIA — An interactive user-friendly program that breaks down diabetes management into four goals to help people with Type 2 diabetes better manage their disease has made its debut.

  • Prevalence of prediabetes, diabetes among adolescents on the rise

    NEW YORK — Being overweight and obesity during adolescence are associated with an increased risk for cardiovascular disease risk factors, especially prediabetes and diabetes, according to researchers.

X
This ad will auto-close in 10 seconds